All AbMole products are for research use only, cannot be used for human consumption.
JNJ-47965567 is a potent and selective P2X7 antagonist (pIC50 values are 8.3, 7.5 and 7.2 for human, mouse and rat receptors respectively). Selective over a panel of 50 other receptors, ion channels and transporters. JNJ-47965567 reduces BzATP-induced IL-1β release from monocytes in vitro and from rat brain in vivo. JNJ-47965567 attenuates amphetamine-induced hyperactivity in rats. Brain penetrant.
Purinergic Signal. 2026 Apr 15; .
P2X7 receptor mediates the anti-tumor effect of running on cervical cancer in mice
JNJ-47965567 purchased from AbMole
| Cell Experiment | |
|---|---|
| Cell lines | Hela and SiHa cells |
| Preparation method | Lactate dehydrogenase (LDH) test kit was used to assess thecytotoxicity of atractylenolide Iand in combination with or without 100 μM BzATP or 20 μM JNJ47965567. Cells were cultured in 96-well plates (6 × 10^3 cells/well). After treatment with the designed concentrations of drugs, cell culture supernatant was transferred to the new 96-well plate for LDH analysis. |
| Concentrations | 20 μM |
| Incubation time | 24 h ~ 72 h |
| Animal Experiment | |
|---|---|
| Animal models | C57BL/6J |
| Formulation | DMSO (10%) and PEG400 (90%) |
| Dosages | 30 mg/kg/day (5 Days) |
| Administration | Intraperitoneal injection |
| Molecular Weight | 488.64 |
| Formula | C28H32N4O2S |
| CAS Number | 1428327-31-4 |
| Form | Solid |
| Solubility (25°C) | DMSO 80 mg/mL 1eq. HCl 20 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related P2 Receptor Products |
|---|
| GW 791343 dihydrochloride
GW 791343 dihydrochloride is a non-competitive inhibitor of human P2X(7) receptor. |
| MRS 2578
MRS2578 is a potent P2Y6 receptor antagonist with IC50 of 37 nM, exhibits insignificant activity at P2Y1, P2Y2, P2Y4,and P2Y11 receptors. |
| PPADS Tetrasodium
PPADS tetrasodium salt is a non-selective P2 purinergic antagonist blocking recombinant P2X1, P2X2, P2X3, P2X5 with IC50 of 1-2.6 μM, native P2Y2-like with IC50 of ~ 0.9 mM, and recombinant P2Y4 receptors with IC50 of ~ 15 mM |
| Ticagrelor
Ticagrelor is the first reversibly binding oral P2Y12 receptor antagonist with Ki of 2 nM respectively. |
| GW791343 trihydrochloride
GW791343 trihydrochloride is ahydrochloride salt form of GW791343, which is a non-competitive allosteric modulator of human P2X7 receptor inhibitor with pIC50 of 7. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
